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Functioning MRIAbstract Aim of the work: To assess the value of diffusion weighted MRI in the differentiation of
benign and malignant bony tumors and tumor like lesions.
Patients and methods: This study included 100 patients (66 males and 34 females). Their ages ran-
ged between 4 and 65 years and the mean age was 31.3 years. The patients were referred to MRI
unit from orthopedic surgery and radiotherapy departments and oncology center in Mansoura Uni-
versity hospital. These patients were selected on clinical bases indicating or suggesting presence of
bony tumors or tumor-like lesions as a primary diagnosis (e.g. swelling or signs of inﬂammation).
The commonest clinical presentations were pain (n= 71) and swelling (n= 61). Other presenta-
tions included limitation of movement (n= 20), back pain (n= 21) and fever (n= 20). More than
one symptom may be present in one patient. Patients included in our study were classiﬁed according
to the pathological and radiological criteria into three groups: Benign bone tumors (14 patients);
malignant bone tumors (51 patients); tumor-like lesions (35 patients).
Results: DWI with measurement of ADC values helped in the differentiation of benign and malig-
nant bone tumors, as malignant bone tumors have mean ADC values less than (1.31 · 103) mm2/s;
while benign bone tumors have mean ADC values 1.43 · 103 mm2/s. Also, mean ADC values
helped in differentiating malignant from inﬂammatory bony lesions as well as cystic from solid bony
lesions.
Conclusion: DWI has been proven to be highly useful in the differentiation of benign, malignant
bone tumors and tumor like bony lesions. Measurement of ADC values improves the accuracy
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be used in the follow up of tumors and their response to therapy.
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All imaging methods play a role in diagnosis of bone tumors.
Plain radiography is the primary imaging modality to suggest
the diagnosis and judge the nature of different bony lesions.
CT is excellent for providing information about the anatomical
extent of bony tumors (1).
MRI is the most sensitive imaging modality for detection of
bony tumors and tumor like lesions. It is considered the gold
standard for characterization of these lesions and can detect
occult intra-medullary lesions with negative bone scan (2).
Moreover, MRI is ideal for imaging bone marrow because
of its superior ability to produce high resolution images with
exquisite soft-tissue contrast (3).
Improvement of treatment and outcome of bone tumors
require development of diagnostic tools that can help in
differentiation between benign and malignant lesions in a
non invasive and reliable manner (4). Diffusion-weighted
magnetic resonance imaging (DWI) is a recent addition topatient, 22 years old complaining
ar lobulated osteolytic lesion hav
all of sclerosis. (D and E): Sagitta
d the signal void sclerotic wall.
n at b value 1000. (H) ADC mathe MR sequences conventionally employed. DWI
provides qualitative and quantitative functional information
concerning the microscopic movements of water at the cellular
level (5).
The application of DW-MRI in bone marrow is today an
established examination technique that provides a unique con-
trast and that can help in the detection of bone-marrow
pathologies and the differentiation of benign and malignant
bone-marrow lesions. It has been applied particularly success-
ful in DWI studies of vertebral lesions and of vertebral com-
pression fractures (6).
Literature has shown value of DWI for assessment of post-
therapeutic response in primary bone tumors such as osteo-
genic and Ewing’s sarcoma (5). Several studies have shown
that there are signiﬁcant differences in ADC values between
patients who responded to treatment (and had higher ADC tu-
mor values) and those who had no response (7,8). The clear va-
lue of the ability of DWI to highlight post-therapeutic
responders versus non-responders is particularly pertinent asof right knee pain: (A and B) plain X-ray: AP and lateral views of
ing sclerotic margins. (C) Sagittal T1WI showing the low SI of the
l T2 fat suppression and coronal STIR images showing the high SI
(F and G): diffusion-weighted images at different b values (0 and
p showing the mean ADC value about 1.27 · 103 mm2/s.
Table 1 Showing different patterns of DWI in different cases
of benign and malignant bone tumors and tumor like lesions.
Type of bony
lesion
No. DWI at b= 1000 s/mm2
Restricted (high SI) Unrestricted (low SI)
Benign 14 – 14
Malignant 51 26 25
Tumor-like 35 5 30
Total 100 31 69
From this table we have noticed that:
All benign lesions show free diffusion.
Malignant lesions may show free or restricted diffusion.
Most of tumors like lesions show free diffusion as benign lesions.
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between the two groups (9).
2. Patients and methods
2.1. Patient selection and clinical assessment
This study included 100 patients (66 males and 34 females).
Their ages ranged between 4 and 65 years, mean age
31.3 years.
The patients were referred to MRI unit from orthopedic
surgery and radiotherapy departments and oncology center
in Mansoura University hospital. These patients were selected
on clinical bases indicating or suggesting presence of bony tu-
mors or tumor-like lesions as a primary diagnosis (e.g. swelling
or signs of inﬂammation). The commonest clinical presenta-
tions were pain (n= 71) and swelling (n= 61). Other presen-
tations included limitation of movement (n= 20), back pain
(n= 21) and fever (n= 20). More than one symptom may
be present in one patient.
Patients included in our study were classiﬁed according to
the pathological and radiological criteria into three groups:
(a) Benign bone tumors (14 patients).
(b) Malignant bone tumors (51 patients).
(c) Tumor-like lesions (35 patients).
2.2. Radiological assessment
(A) Plain X-ray: it was the initial step, carried out for the
suspected region in all patients. Routine antero-poster-Table 2 Showing different patterns of DWI and ADC values in di
Type of bony lesion No. Unrestricted (low SI) (on DWI at b
Osteoid osteoma 1 1
Chondroblastoma 2 2
Osteochondroma 3 3
Enchondroma 1 1
Hemangioma 5 5
Non ossifying ﬁbroma 1 1
Fibrous cortical defect 1 1
Total 14 14
From this table we have concluded that:
The mean ADC value for benign chondroid tumors is about (2.15 · 103
The mean ADC value for other benign tumors is about (1.43 · 103) mmior and lateral views were done in addition to any special
views if needed, such as oblique views.
(B) Computed tomography (CT): CT scans were carried out
for 11 patients while 14 patients had their CT study
performed before they were referred to us. CT was
performed in the CT unit, in radiodiagnosis department
of Mansoura University hospital; using Toshiba spiral
CT machine (Asteion). Axial scans were done, from
above to below the level of the lesion with 5–10 mm
slice thickness. Thinner slices (3 mm) were needed to
assess small lesions such as the detection of the nidus
of osteoid osteoma or the sequestrum of osteomyelitis.
Images were reviewed using both soft tissue and bone
windows.
(C) MR examination (MR): done for all patients (n= 100),
using the following protocol:
Conventional MRI (n = 100): suitable body or surface coil
was used according to the site and extent of the lesion. Slice
thickness (5–10 mm), interslice gap (1–2 mm), ﬁeld of
view (20–40 cm) and matrix (128 · 256). T1WI; short
TR/TE:{TR/TE = 500/14 ms. NEX= 1–2}. T2WI long
TR/TE: {TR/TE = 2000–4000/30–90 ms NEX= 3}.
STIR, short tau inversion recovery: {TR/TE = 1420–
1680/20–40 ms, Inversion (TI) = 150}. GRE, gradient
echo: {TR/TE = 400–600/20–25 ms NEX= 2.4}. Flip
angle = 20–25.
Post contrast study: multiplanar T1 fat suppression was
obtained (n= 7), immediately after intravenous adminis-
tration of Magnivest (Gadoloinium DPTA) in a dose of
0.1 mmol/kg.
Diffusion weighted MR imaging (DWI): DW images were
obtained for all patients (n= 100). They were obtained
using a multisection single shot spin echo-planar sequence
(TR/TE/NEX: 2200/139MS/1) with diffusion sensitivities
of b values = 0, 500 and 1000 s/mm2. Diffusion gradients
were applied sequentially in three orthogonal directions
(X, Y and Z). Sections of 5 mm thickness, interslice gap
of 1 mm, ﬁeld of view 240–400 mm and 128 · 256 matrix
were used for all images. Scanning time was about 120 s.
The number of slices varied from patient to another, chosen
in a manner that covered the entire tumor with an extra
slice in each direction.
Post processing of DWI: four sets of DWIs for each section
were obtained. The ﬁrst 3 sets of images (trace images) cor-
responding to sequential application of the sensitization
gradient in the X, Y and Z planes. The last set (ADC map)fferent cases of benign tumors (14 cases).
= 1000 s/mm2) Solid component (Mean ADC value in mm2/s)
1.36
2.19
2.16
2.11
1.61
1.27
1.58
) mm2/s.
2/s.
Fig. 2 Osteomyelitis: male patient aged 30 years old complaining of right lower thigh painful, swelling and fever: (A) Plain X-ray (lateral
view) of the left distal femur showing an ill deﬁned osteolytic lesion. (B) Sagittal T1WI showing the low SI of the lesion and the
surrounding bone marrow. (C) Sagittal T2WI, with fat suppression showing the high SI of the lesion and the surrounding bone marrow.
(D and E) Axial CT scan (bone window) showing small bony sequestra. (F and G) diffusion weighted images at b values (0 and 1000):
showing non restricted diffusion I the peripheral parts (bone marrow edema) and high signal in the central part of the lesion (restricted
diffusion). (H) ADC map showing the mean ADC value in the central part (0.9 · 103) mm2/s, while in the solid part (1.56 · 103) mm2/s.
470 S.Z. Kotb et al.corresponding to the average diffusion images where ADC
measurement for any point or ROI can be measured. The
trace images were obtained at different b values: 0, 500 and
1000.
Interpretation of diffusion weighted images:
1- The lesion was determined on DWI and ADC map by
using the conventional MR images as a guide.
2- Signal intensity of the lesion on DWIs (b1000) is deter-
mined: either hypointense (free diffusion) or hyperin-
tense (restricted diffusion).3- Measurements of the apparent diffusion coefﬁcient
(ADC) were made using electronic cursor on the ADC
map in different regions of interest (ROI) of the
lesions and in comparable contralateral regions of
normal tissue. The ADC values were expressed in
·103 mm2/s.
4- The ROI for each lesion was placed at least 3 times, and
then the mean ADC value for the lesion was calculated.
Both solid parts and cystic parts (if present) of the
tumors were assessed. ROI is placed the solid
portion of the solid tumors and in the center of cystic
lesions.
Fig. 3 Ewing’s sarcoma: 21 year old female complaining of swelling and pain of the left radius: (A) Plain X-ray (AP and lateral views) of
the left radius: showing diffuse sclerosis and periosteal reaction. (B and C) Sagittal and axial T1WIs showing lesion of intermediate SI and
the cortical defect through which the lesion is passing outside the medullary cavity to form a soft tissue mass. (D and E) Sagittal STIR and
axial T2WI showing high SI of the bony lesion and the associated soft tissue mass. (F and G): diffusion-weighted images at different b
values (0 and 1000): showing high signal at b 1000 (restricted diffusion). (H) ADC map showing the mean ADC value about (0.7 · 103)
mm2/s.
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maps was evaluated, with the exclusion of non accept-
able images that contained distortion or ghosting
artifact.
2.3. Pathological assessment
MRI ﬁndings have been correlated with the pathological re-
sults obtained from either surgical excision or needle biopsy.
3. Results
DWI with measurement of ADC values helped in the differen-
tiation of:
 Benign and malignant bone tumors, as malignant bone
tumors usually have mean ADC values less than
(1.31 · 103) mm2/s; while benign bone tumors have mean
ADC values (1.43 · 103) mm2/s. Malignant bone tumors and inﬂammatory bony lesions:
mean ADC values, more than (1.5 · 103) mm2/s. So,
Ewing’s sarcoma could be easily differentiated from
osteomyelitis.
 Cystic from solid lesions(without the use of contrast media)
as cystic lesions usually have mean ADC value more than
(2 · 103) mm2/s.
 DWI by measuring ADC values can be used in the follow
up of tumors and their response to therapy as tumor cell
necrosis resulting from therapy makes diffusion more free
with subsequent increased mean ADC values.
 Chondroid tumors usually have high ADC values (more
than 2 · 103) mm2/s; with no signiﬁcant differences
between benign and malignant chondroid lesions.
 Tumor like lesions: inﬂammatory lesions are the commonest
tumor like lesions (57%). They have high ADC values:
more than (1.5 · 103 mm2/s) making it easily differentiated
from Ewing’s sarcoma. Cystic areas (abscesses) of untreated
osteomyelitis show restricted diffusion with low ADC val-
ues due to the high viscosity of their content making water
motion restricted. Cystic lesions like ABC and simple bone
Fig. 4 Lymphoma: 17 year old male complaining of swelling and
pain of the left knee: (A) Plain X-ray (AP view) of the left tibia:
showing diffuse patchy sclerotic lesion mixed with osteolytic areas.
(B and C) Sagittal and axial T1WIs intermediate SI of the lesion
and the associated soft tissue component. (D and E) Axial T2WI
and GRE images showing mixed high SI of the bony lesion and
the associated soft tissue mass. (F and G): diffusion-weighted
images at different b values (0 and 1000): showing high signal at b
1000 (restricted diffusion). (H) ADC map showing the mean ADC
value about (1.2 · 103) mm2/s.
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effect, but usually have high mean ADC values on ADC
map (more than 2 · 103 mm2/s).Statistical analysis for the mean ADC values measured in
the solid part of the bone tumor, revealed the following:
 There was a signiﬁcant statistical difference between malig-
nant and non malignant lesions (benign and tumor like
lesions) (P= 0.001).
 There was no signiﬁcant statistical difference between
benign and tumor like lesions.
 There was signiﬁcant statistical difference between malig-
nant and tumor like lesions (P= 0.007).
 There was no signiﬁcant statistical difference between
benign and malignant lesions.
 However, after the exclusion of chondrosarcomas from
malignant lesions, there was signiﬁcant statistical difference
between benign and malignant lesions (P= 0.00).
4. Discussion
The advantages of MRI permit the precise evaluation of the
aggressiveness of different lesions through detection of their
extent and muscle inﬁltration (as in malignant tumors and
inﬂammatory lesions). So, we are in agreement with Harms
and Greenway, 1992 (10); who stated that MRI is helpful in
the evaluation of the aggressiveness of different lesions.
In our study we have found that, after exclusion of chon-
droid tumors, the ADC values of benign bony tumors
(n= 8) ranged from 1.26 to 1.58 · 103 mm2/s (Fig. 1); with
the mean ADC value about (1.43 · 103) mm2/s. (Table 2).
Chondroid tumors should be excluded because they have a
special character where the lesions show no signiﬁcant differ-
ence between ADC values calculated in benign and malignant
lesions (Table 5) due to the characteristic nature of the chon-
droid matrix which has a high ﬂuid content; as explained by
Hayashida et al., 2006 (9,11) (Fig. 2).
Five cases of osseous hemangiomas (Fig. 5) were included
in our study and they had ADC value of about
1.6 · 103 mm2/s but this differs from that stated by Einars-
dottir et al., 2004 (12) who found that ADC value of hemangi-
oma was 1.10 · 103 mm2/s. These results are considered
relatively low for a highly vascular benign tumor, but Kim
et al., 1998 (13) attributed the low ADC values in some heman-
giomas to the fact that hemangioma sometimes contains ﬁ-
brous tissue and thrombosis in its vascular spaces which
causes reduction in its ADC values.
Inﬂammatory lesions (Fig. 2) are the commonest tumor-like
lesions (57%) (Fig. 6). They have high ADC values
(1.5 · 103 mm2/s) making it easily differentiated from Ew-
ing’s sarcoma. Cystic area (abscesses) of untreated osteomyeli-
tis shows restricted diffusion with low ADC value due to high
viscosity of its content making water motion restricted (Ta-
ble 4). This is in agreement with Wong et al., 2004 (14) who
stated that abscess has restricted diffusion with low ADC value
due to high viscosity of its content caused by pus, inﬂamma-
tory cells and granulation tissue.
In this study, ADC values of solid malignant tumors
(n= 51) ranged from 0.6 to 2.05 · 103 mm2/s with mean
ADC (1.39 · 103 mm2/s) (Fig. 3). After exclusion of
chondrosarcoma, all other malignant tumors will be ranged
from 0.6 to 1.8 · 103 mm2/s with mean ADC (n= 48)
(1.39 · 103 mm2/s) (Table 3). This was nearly in agreement
Fig. 5 Hemangioma: 17 year old male complaining of swelling and pain of the left knee: (A) Axial T1 and T2WI showing high SI of the
lesion on both pulse sequences. (B and C): diffusion-weighted images at different b values (0 and 1000): showing complete absence of the
lesion at b 1000 image (non restricted diffusion). (D) ADC map showing the mean ADC value about (1.4 · 10–3) mm2/s.
Table 3 Showing different patterns of DWI and ADC values in different cases of malignant tumors (51 cases).
Type of bony lesion No. Appearance on DWI at b= 1000 s/mm2 Mean ADC value ·103 mm2/s
Restricted (high SI) Unrestricted (low SI) Solid component Cystic component
Osteosarcoma 13 5 8 1.39 –
Chondrosarcoma 3 1 2 2.05 –
Lymphoma 9 4 5 1.7 –
Ewing’s sarcoma 8 4 4 1.18 2.3
Plasmacytoma 2 1 1 1.1 –
Leukemia 1 1 – 0.9 –
Multiple myeloma 1 – 1 1.44 –
Ameloblastoma 1 1 – 1.53
Metastatic 13 9 4 1.21
Total 51 26 25
From this table we have concluded that:
The mean ADC value for malignant chondroid tumors is about (2.05 · 103) mm2/s.
The mean ADC value for other malignant tumors is about (1.31 · 103) mm2/s.
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of cartilaginous tumors from other malignant tumors due to
their high shooting values on ADC maps (Table 6).
In the present study, we had 9 cases of lymphoma, 4 out of
them showed restricted diffusion while the remaining 5 cases
showed free diffusion (Fig. 4). The mean ADC value was
about 1.7 · 103 mm2/s; ranging from 1.02 to1.9 · 103 mm2/s. This was not in agreement with Barboriak,
2003 (16) who reported strongly reduced ADC (0.64 · 10–3
mm2/s) and Guo et al., 2002 (17) who stated that lymphoma
in brain had lower ADC values compared to other tumors.
This high ADC and non restricted diffusion in our cases of
lymphoma may be cleared out by what was mentioned by
Holscher et al., 1996 (18) who stated that the two most
Fig. 6 Aneurysmal bone cyst (ABC): 15 year old male complaining of pain of the left hip: CT scan of the pelvic bones: showing an
expansile bony lesion affecting the left acetabulum. Axial T1WI showing intermediate SI of the lesion which has intra-pelvic extension,
with mild compression of the urinary bladder and rectum. (C and D) Axial T2WI and coronal T2 fat suppressed image: showing mixed
high SI of the bony lesion with the presence of ﬂuid-ﬂuid levels. (E) Post contrast axial T1WI with fat suppression showing the enhancing
septae of the lesion. (F) diffusion-weighted images at different b values (0 and 1000): showing high signal at b 1000 diffusion weighted
image. (H) ADC map showing the mean ADC value about (2.1 · 10–3) mm2/s.
Table 4 Showing different patterns of DWI and ADC values in different cases of tumor-like lesions (35 cases).
Type of bony lesion No. Appearance on DWI at b= 1000 s/mm2 Mean ADC value ·103 mm2/s
Restricted (high SI) Unrestricted (low SI) Solid component Cystic component
Inﬂammatory 20 3 16 1.58 2.13
ABC 6 1 6 – 2.48
Simple bone cyst 2 1 1 – 2.6
Fibrous dysplasia 4 – 4 0.97 2.04
Bone marrow edema 3 – 3 1.63 –
Total 35 5 30
From this table we have concluded that:
The mean ADC value for solid tumor-like lesions is about (1.39 · 103) mm2/s.
The mean ADC value for cystic tumor-like lesions is about (1.31 · 103) mm2/s.
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water molecules in the extra cellular space and perfusion.
Accordingly, Van Rijswijk et al., 2002 (19) explained the over-
lapped ADC values by the contribution of perfusion to the
ADC values. The perfusion fraction of malignant tumor tends
to be higher due to increased tumor cell packing than that of
benign masses.Thirteen cases of metastasis were included in this study,
their ADCs values ranged from 0.42 to 1.4 · 103 mm2/s.
The lowest value was of the undifferentiated carcinoma while
the highest one was of differentiated hepatocellular carcinoma
indicating that the more differentiation of a tumor (less packed
cells), the more the diffusion and the higher ADC values. In
this study the ADC of metastatic hepatocellular carcinoma
Table 5 Showing different patterns of DWI and ADC values
in different pathologies (100 cases).
Type of bony lesion No. Mean ADC value ·103 mm2/s
Solid component Cystic component
Benign 14 2.15 (chondroid) -
1.43 (others)
Malignant 51 2.05 (chondroid) 2.3
1.31 (others)
Tumor like 35 1.39 2.31
Total 100
From this table we have concluded that:
Chondroid tumors (benign and malignant) have ADC value more
than (2 · 103) mm2/s.
There is signiﬁcant difference between ADC values of benign and
malignant solid tumors (after exclusion of chondroid tumors).
Table 6 Statistical signiﬁcance on comparing ADC values
(measured in the solid parts) of benign versus malignant bony
lesions.
P value
Malignant and non malignant lesions (benign and tumor
like lesions)
0.001
Benign and tumor like lesions. 852
Malignant and tumor like lesions 0.007
Benign and malignant lesions. 039
Benign and malignant lesions (after the exclusion of
chondrosarcomas)
0.001
P value is signiﬁcant if <0.05.
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2002 (20) who reported that mean ADC of HCC is
1.33 · 103 mm2/s. Furthermore, they suggested that the
threshold ADC for the distinction between benign and malig-
nant liver masses is 1.5 · 103 mm2/s.
Similar to Lang et al., 1998 (21), we found low signal inten-
sity in necrotic tumors on DWIs, indicating rapid diffusion of
water molecules as a result of loss of membrane integrity. This
was demonstrated in two cases of osteosarcoma for which we
did follow up DWIs to monitor tumor response to therapy.
The signal intensity of the lesion decreased on DWIs (at
b= 1000 s/mm2) indicating more free water diffusion caused
by cell necrosis. Similarly ADC values signiﬁcantly increased.
These ﬁndings are similar to those observed by Einarsdottir
et al., 2004 (12) and Hayashida et al., 2006 (9,11).
5. Conclusion
DWI has been proven to be highly useful in the differentiation
of benign, malignant bone tumors and tumor like bony lesions
(Table 1). When combined as a complementary sequence with
conventional MRI with the measurement of ADC values, the
accuracy of the diagnosis of bone tumors and tumor like le-
sions will be improved. Moreover, measurement of ADC val-
ues can be used in the follow up of tumors and their
response to therapy.Conﬂict of interest
None.
References
(1) Bohndrof K. Tumors and tumor like lesions of the skeleton and
soft tissues. In: Bohndrof K, Imhof H, Pope TL et al., editors.
Musculoskeletal imaging (A concise multimodality approach).
New York: Thieme Company, chapter (3); 2004. p. 160–200.
(2) Kaplan PA, Helms CA, Dussalt R et al. Tumors. In: Kaplan PA,
Kaplan PA, Helms CA, Dussalt R et al., editors. Musculoskeletal
MRI. Philadelphia, London, New York: WB Saunders Company,
chapter (7); 2001. p. 23–150
(3) Kung JW, Yablon CM, Eisenberg RL. Bone marrow signal
alteration in the extremities. AJR 2011;196:492–510.
(4) Wang J, Takashima S, Takayama F, et al. Head and neck lesions:
characterization with diffusion-weighted echo-planar imaging.
Radiology 2001;220:621–30.
(5) Khoo MY, Tyler PA, Saifuddin A, Padhani AR. Diffusion-
weighted imaging (DWI) in musculoskeletal MRI: a critical
review. Skeletal Radiol 2011;40:665–81.
(6) Dietrich O, Biffar A, Reiser MF, Baur-Melnyk A. Diffusion-
weighted imaging of bone marrow. Semin Musculoskelet Radiol
2009;13(2):134–44.
(7) Uhl M, Saueressig U, Koehler G, Kontny U, Niemeyer C,
Reichardt W, et al. Evaluation of tumour necrosis during
chemotherapy with diffusion-weighted MR imaging: preliminary
results in osteosarcomas. Pediatr Radiol 2006;36(12):1306–11.
(8) Uhl M, Saueressig U, van Buiren M, Kontny U, Niemeyer C,
Ko¨hler G, et al. Osteosarcoma: preliminary results of in vivo
assessment of tumor necrosis after chemotherapy with diffusion
and perfusion-weighted magnetic resonance imaging. Invest
Radiol 2006;41(8):618–23.
(9) Hayashida Y, Yakushiji T, Awai K, Katahira K, Nakayama Y,
Shimomura O, et al. Monitoring therapeutic responses of
primary bone tumors by diffusion-weighted image: initial results.
Eur Radiol 2006;16(12):2637–43.
(10) Harms SE, Greenway G. Musculoskeletal tumors. In: Stark DD,
Bradley WG, editors 2nd ed. Magnetic resonance imaging. St.
Louis, Baltimore, Boston, Chicago, London, Philadelphia, Syd-
ney, Toronto: Mosby Year Book; 1992. p. 2017.
(11) Hayashida Y, Hirai T, Yakushiji T, Katahira K, Shimomura O,
Imuta M, et al. Evaluation of diffusion-weighted imaging for the
differential diagnosis of poorly contrast-enhanced and T2-pro-
longed bone masses: initial experience. J Magn Reson Imaging
2006;23(3):377–82.
(12) Einarsdottir H, Karlssom M, Wejde J, et al. Diffusion-weighted
MRI of soft tissue tumors. Eur Radiol 2004;14:959–63.
(13) Kim YJ, Chang KH, Song IC. Brain abscess and necrotic or
cystic brain tumors: discrimination with signal intensity on
diffusion-weighted MR imaging. Am J Roentegenol 1998;171:
1487–90.
(14) Wong AM, Zimmerman RA, Simon EM, et al. Diffusion-
weighted MR imaging of subdural empyemas in children. AJNR
2004;25:1016–21.
(15) Nagata S, Nishimura H, Uchida M, et al. Usefulness of
diffusion-weighted MR imaging in differentiating benign from
malignant musculoskeletal tumors. Nippon ACTA Radiologica
2005;65:30–6.
(16) Barboriak DP. New techniques for imaging brain tumors,
including diffusion weighted and diffusion tensor MR. Oncologic
imaging, American Rontegen Ray Society, annual meeting,
Sandiago, California, 2003. p. 11–24.
(17) Guo AC, Cummings TJ, Dash RC, et al. Lymphomas and high
grade astrocytomas: comparison of water diffusibility and histo-
logic characteristics. Radiology 2002;224:177–83.
476 S.Z. Kotb et al.(18) Holscher HC, Hermans J, Nooy MA, et al. Can conventional
radiographs be used to monitor the effect of neoadjuvant
chemotherapy in patients with osteogenic sarcoma? Skeletal
Radiol 1996;25:19–24.
(19) Van Rijswijk CS, Kunz P, Hogendoorn PC, et al. Diffusion
weighted MRI in the characterization of soft tissue tumors. J
Magn Reson Imaging 2002;15:302–7.(20) Taouli B, Vilerie V, Dumont E, et al. Evaluation of diffusion
isotropy and characterization of focal hepatic lesions with two
single shot echo planar MR sequences: prospective study in 66
patients. Radiology 2002;226:71–8.
(21) Lang P, wendland MF, Saeed M, et al. Osteogenic sarcoma: non
invasive invivo assessment of tumor necrosis with diffusion
weighted MR imaging. Radiology 1998;206:227–35.
